Cargando…
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that primarily originate from the bile duct. Tumor heterogeneity is a prime characteristic of CCA and considering the scarcity of approved targeted therapy drugs, this makes precision oncology impractical in CCA. Stratifying patients...
Autores principales: | Balasubramanian, Brinda, Venkatraman, Simran, Janvilisri, Tavan, Suthiphongchai, Tuangporn, Jitkaew, Siriporn, Sripa, Jittiyawadee, Tohtong, Rutaiwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469883/ https://www.ncbi.nlm.nih.gov/pubmed/34577598 http://dx.doi.org/10.3390/ph14090898 |
Ejemplares similares
-
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2022) -
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach
por: Venkatraman, Simran, et al.
Publicado: (2022) -
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2023) -
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2021) -
Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells
por: Seeree, Pattaya, et al.
Publicado: (2019)